scispace - formally typeset
Search or ask a question
JournalISSN: 1179-8475

Research Reports in Clinical Cardiology 

Dove Medical Press
About: Research Reports in Clinical Cardiology is an academic journal published by Dove Medical Press. The journal publishes majorly in the area(s): Medicine & Heart failure. It has an ISSN identifier of 1179-8475. It is also open access. Over the lifetime, 151 publications have been published receiving 858 citations. The journal is also known as: Journal of research reports in clinical cardiology.


Papers
More filters
Journal ArticleDOI
TL;DR: It is proposed that the adoption of diet and lifestyle that mimic the beneficial characteristics of the preagricultural environment is an effective strategy to reduce the risk of chronic degenerative diseases.
Abstract: Correspondence: Pedro Carrera-Bastos R. Gorgel do Amaral, No. 5, 1 e; Lisbon 1250-119, Portugal Tel +351 967 088 799 email pedro.carrera_bastos@med.lu.se Abstract: It is increasingly recognized that certain fundamental changes in diet and lifestyle that occurred after the Neolithic Revolution, and especially after the Industrial Revolution and the Modern Age, are too recent, on an evolutionary time scale, for the human genome to have completely adapted. This mismatch between our ancient physiology and the western diet and lifestyle underlies many so-called diseases of civilization, including coronary heart disease, obesity, hypertension, type 2 diabetes, epithelial cell cancers, autoimmune disease, and osteoporosis, which are rare or virtually absent in hunter–gatherers and other non-westernized populations. It is therefore proposed that the adoption of diet and lifestyle that mimic the beneficial characteristics of the preagricultural environment is an effective strategy to reduce the risk of chronic degenerative diseases.

269 citations

Journal ArticleDOI
TL;DR: This work is licensed to www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/ 3.0/).
Abstract: php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Research Reports in Clinical Cardiology 2018:9 33–45 Research Reports in Clinical Cardiology Dovepress

35 citations

Journal ArticleDOI
TL;DR: This work is licensed to www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/ 3.0/).
Abstract: php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Research Reports in Clinical Cardiology 2017:8 21–29 Research Reports in Clinical Cardiology Dovepress

33 citations

Journal ArticleDOI
TL;DR: ASBP and aAIx measured using the BPLab device equates significantly with the same parameters measured by SphygmoCor, which allows the recommendation of Vasotens technology, which can be used with the 24-hour B PLab monitoring system for wide clinical use.
Abstract: Correspondence: Anatoliy N Rogoza Cardiology Research Complex, 3rd Cherpkovskaya str, 15a 121552, Moscow, Russian Federation Tel +7 4991490806 Fax +7 8312961415 Email rogoza@24h-monitoring.com Introduction: The aim of this study is the comparison of Vasotens technology as used in a device with an oscillometric method of blood pressure measurement (BPLab, Petr Telegin Ltd, Nizhny Novgorod, Russian Federation) against the validated tonometric system (SphygmoCor, AtCor Medical Pty Ltd, West Ryde, Australia). Methods: The examinations were carried out in two medical centers. Exclusion criteria included atrial fibrillation, severe cardiac anomalies, heart failure, arrhythmia, decompensated diabetes, the presence of an artificial pacemaker, pregnancy, and BMI . 30. Overall, 160 patients and healthy volunteers were examined. Central aortic systolic blood pressure (aSBP) and augmentation index (aAIx) were obtained by means of applanation tonometry and the oscillometric method was compared. Results: aSBP and aAIx measured using the BPLab device equates significantly with the same parameters measured by SphygmoCor. Conclusion: This finding allows the recommendation of Vasotens technology, which can be used with the 24-hour BPLab monitoring system for wide clinical use.

27 citations

Journal ArticleDOI
TL;DR: The importance of LDL-P in the surprising presentation of vascular disease in a woman who had a high concentration of high-density lipoprotein cholesterol (HDL-C) is illustrated, so patients can be appropriately selected to receive suitable medication, leading to better health outcomes.
Abstract: Correspondence: Tara Dall Advanced Lipidology, 524 Milwaukee Street #180, Delafield, WI 53018, USA Tel +1 262 646 3223 Fax +1 262 646 3443 email taradall@advlip.com Abstract: Despite adequate screening and low-density lipoprotein cholesterol (LDL-C)-lowering therapy, it has been recognized that many patients with low or moderate LDL-C levels experience cardiovascular events. Furthermore, many patients with cardiovascular disease and relatively normal levels of LDL-C have increased levels of low-density lipoprotein particles (LDL-P). The purpose of this case report is to illustrate the importance of LDL-P in the surprising presentation of vascular disease in a woman who had a high concentration of high-density lipoprotein cholesterol (HDL-C). By utilizing lipoprotein information, patients can be appropriately selected to receive suitable medication, leading to better health outcomes.

26 citations

Performance
Metrics
No. of papers from the Journal in previous years
YearPapers
20236
202212
20218
20208
20196
20185